NO973822L - Benzotiazin-dioksyder som endotelin-antagonister - Google Patents

Benzotiazin-dioksyder som endotelin-antagonister

Info

Publication number
NO973822L
NO973822L NO973822A NO973822A NO973822L NO 973822 L NO973822 L NO 973822L NO 973822 A NO973822 A NO 973822A NO 973822 A NO973822 A NO 973822A NO 973822 L NO973822 L NO 973822L
Authority
NO
Norway
Prior art keywords
endothelin
endothelin antagonists
preparation
benzothiazine dioxides
dioxides
Prior art date
Application number
NO973822A
Other languages
English (en)
Other versions
NO973822D0 (no
NO308897B1 (no
Inventor
Kent Alan Berryman
Amy Mae Bunker
Annette Marian Doherty
Jeremy John Edmunds
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of NO973822D0 publication Critical patent/NO973822D0/no
Publication of NO973822L publication Critical patent/NO973822L/no
Publication of NO308897B1 publication Critical patent/NO308897B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/021,2-Thiazines; Hydrogenated 1,2-thiazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Dental Preparations (AREA)
  • Polyesters Or Polycarbonates (AREA)
NO973822A 1995-02-21 1997-08-20 Benzotiazin-dioksyder som endotelin-antagonister, fremgangsmÕter for fremstilling derav, farmasøytiske preparater omfattende forbindelsene, samt anvendelse av forbindelsene NO308897B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/393,143 US5599811A (en) 1995-02-21 1995-02-21 Benzothiazine dioxides as endothelin antagonists
PCT/US1996/001093 WO1996026195A1 (en) 1995-02-21 1996-01-26 Benzothiazine dioxides as endothelin antagonists

Publications (3)

Publication Number Publication Date
NO973822D0 NO973822D0 (no) 1997-08-20
NO973822L true NO973822L (no) 1997-08-21
NO308897B1 NO308897B1 (no) 2000-11-13

Family

ID=23553452

Family Applications (1)

Application Number Title Priority Date Filing Date
NO973822A NO308897B1 (no) 1995-02-21 1997-08-20 Benzotiazin-dioksyder som endotelin-antagonister, fremgangsmÕter for fremstilling derav, farmasøytiske preparater omfattende forbindelsene, samt anvendelse av forbindelsene

Country Status (27)

Country Link
US (1) US5599811A (no)
EP (1) EP0811001B1 (no)
JP (1) JPH11501013A (no)
KR (1) KR19980702358A (no)
CN (1) CN1071327C (no)
AT (1) ATE207911T1 (no)
AU (1) AU720036B2 (no)
BG (1) BG62613B1 (no)
CA (1) CA2211027A1 (no)
CZ (1) CZ294412B6 (no)
DE (1) DE69616515T2 (no)
DK (1) DK0811001T3 (no)
EE (1) EE03564B1 (no)
ES (1) ES2167544T3 (no)
FI (1) FI973380A (no)
GE (1) GEP20001969B (no)
HU (1) HUP9800273A3 (no)
NO (1) NO308897B1 (no)
NZ (1) NZ302116A (no)
PL (1) PL321866A1 (no)
PT (1) PT811001E (no)
RO (1) RO116898B1 (no)
RU (1) RU2164225C2 (no)
SK (1) SK284275B6 (no)
UA (1) UA47424C2 (no)
WO (1) WO1996026195A1 (no)
ZA (1) ZA961342B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962490A (en) * 1987-09-25 1999-10-05 Texas Biotechnology Corporation Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US6342610B2 (en) 1993-05-20 2002-01-29 Texas Biotechnology Corp. N-aryl thienyl-, furyl-, and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US6541498B2 (en) 1993-05-20 2003-04-01 Texas Biotechnology Benzenesulfonamides and the use thereof to modulate the activity of endothelin
US6030991A (en) * 1993-05-20 2000-02-29 Texas Biotechnology Corp. Benzenesulfonamides and the use thereof to modulate the activity of endothelin
US6613804B2 (en) 1993-05-20 2003-09-02 Encysive Pharmaceuticals, Inc. Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
US6376523B1 (en) 1994-05-20 2002-04-23 Texas Biotechnology Corporation Benzenesulfonamides and the use thereof to modulate the activity of endothelin
ES2202449T3 (es) * 1995-06-02 2004-04-01 SHIONOGI & CO., LTD. Inhibidor de edema cerebral.
US5804585A (en) 1996-04-15 1998-09-08 Texas Biotechnology Corporation Thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin
US5783705A (en) * 1997-04-28 1998-07-21 Texas Biotechnology Corporation Process of preparing alkali metal salys of hydrophobic sulfonamides
TR200101905T2 (tr) 1997-04-28 2002-06-21 Texas Biotechnology Corporation Endotelin ile ilgili hastalıkların tedavisinde kullanılan sülfanoamidler.
CN1268942A (zh) 1997-06-27 2000-10-04 藤泽药品工业株式会社 磺酰胺化合物及其药物用途
US6265399B1 (en) * 1997-09-05 2001-07-24 Warner-Lambert Company Certain benzothiazine dioxide endothelin antagonists and processes for their preparation
GB2337048B (en) * 1998-05-05 2000-06-28 Warner Lambert Co 2,1,3-Benzothiadiazole containing endothelin antagonists
JP2003535061A (ja) * 2000-05-31 2003-11-25 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー エンドセリン受容体拮抗剤および疼痛軽減特性を有する抗癲癇化合物または鎮痛剤の複合物
US20020115661A1 (en) * 2000-12-07 2002-08-22 Keller Laurence Harvey Method for treating chronic obstructive pulmonary disease
RU2435585C2 (ru) * 2006-04-13 2011-12-10 Актелион Фармасьютиклз Лтд Антагонисты рецептора эндотелина, предназначенные для ранней стадии идиопатического фиброза легких
FR2942797B1 (fr) * 2009-03-03 2011-04-29 Pf Medicament Derives de benzothiazines, leur preparation et leur application a titre de medicaments
US10865201B2 (en) 2016-09-12 2020-12-15 Valo Health, Inc. Bicyclic compounds useful as GPR120 modulators
CN114671827A (zh) * 2020-12-24 2022-06-28 杭州百新生物医药科技有限公司 邻苯甲酰磺酰亚胺类衍生物及其应用
CN112521384B (zh) * 2021-01-13 2021-11-02 湖北大学 溶剂热一锅法合成苯并噻嗪并环戊二烯衍生物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3237473A1 (de) * 1982-10-09 1984-04-12 Dr. Karl Thomae Gmbh, 7950 Biberach Neue 4-hydroxy-2h-1,2-benzothiazin-3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung, ihre verwendung und diese verbindungen enthaltende arzneimittel
CA2032559C (en) * 1989-12-28 2001-11-06 Kiyofumi Ishikawa Endothelin antagonistic cyclic pentapeptides
JPH0441483A (ja) * 1990-06-07 1992-02-12 Tanabe Seiyaku Co Ltd ベンゾチアジン誘導体及びその製法
JP2667294B2 (ja) * 1991-11-05 1997-10-27 スミスクライン・ビーチャム・コーポレイション エンドセリン受容体拮抗剤
US5389620A (en) * 1993-08-18 1995-02-14 Banyu Pharmaceutical Co., Ltd. Endothelin antagonistic heteroaromatic ring-fused cyclopentene derivatives

Also Published As

Publication number Publication date
AU720036B2 (en) 2000-05-18
DE69616515T2 (de) 2002-05-16
WO1996026195A1 (en) 1996-08-29
MX9706024A (es) 1997-11-29
EP0811001A1 (en) 1997-12-10
FI973380A0 (fi) 1997-08-18
NO973822D0 (no) 1997-08-20
US5599811A (en) 1997-02-04
CZ260797A3 (cs) 1998-06-17
CN1180351A (zh) 1998-04-29
EE9700147A (et) 1997-12-15
NZ302116A (en) 1998-06-26
CN1071327C (zh) 2001-09-19
SK114697A3 (en) 1998-08-05
ES2167544T3 (es) 2002-05-16
BG62613B1 (bg) 2000-03-31
EP0811001B1 (en) 2001-10-31
PL321866A1 (en) 1997-12-22
GEP20001969B (en) 2000-03-05
ZA961342B (en) 1996-08-26
RO116898B1 (ro) 2001-07-30
HUP9800273A3 (en) 1999-09-28
CA2211027A1 (en) 1996-08-29
EE03564B1 (et) 2001-12-17
KR19980702358A (ko) 1998-07-15
NO308897B1 (no) 2000-11-13
FI973380A (fi) 1997-08-20
JPH11501013A (ja) 1999-01-26
CZ294412B6 (cs) 2004-12-15
RU2164225C2 (ru) 2001-03-20
AU4770396A (en) 1996-09-11
PT811001E (pt) 2002-04-29
SK284275B6 (sk) 2004-12-01
UA47424C2 (uk) 2002-07-15
DK0811001T3 (da) 2002-02-18
BG101867A (en) 1998-10-30
ATE207911T1 (de) 2001-11-15
DE69616515D1 (de) 2001-12-06
HUP9800273A2 (hu) 1999-07-28

Similar Documents

Publication Publication Date Title
DK0811001T3 (da) Benzothiazindioxider som endothelinantagonister
DK1094816T3 (da) Biphenylsulfonamider som dobbelte angiotensin-endothelin-receptorantagonister
WO2001044239A3 (en) Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
TR200100267T2 (tr) İkameli anilid bileşimleri ve yöntemler.
EA200100972A1 (ru) Новые соединения и композиции как ингибиторы протеаз
DE69725825D1 (de) 5-HT1F-Agonisten
FI973221A (fi) 1-aryyli-2-asyyliammo-etaaniyhdisteitä ja niiden käyttö neurokiniiniantagonisteina, erityisesti neurokiniini 1 antagonisteina
ATE195948T1 (de) Endothelinantagonisten
ES2088128T3 (es) Aminosulfonilureas inhibidoras de acat.
NO20021503L (no) Kinazolinoner
MY116277A (en) Certain benzothiazine dioxide endothelin antagonists and processes for their preparation
NO20002408L (no) 5-HT1F antagonister
ID27656A (id) Turunan azabisikloheptana n-tersubstitusi, pembuatan dan penggunaannya
BR9713644A (pt) Composto cianofosforosos e sua preparação.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees